Homarylamine
Jump to navigation
Jump to search
Template:Short description Template:Drugbox
Homarylamine (INN;[1] also known as 3,4-methylenedioxy-N-methylphenethylamine and MDMPEA) is an antitussive (anti-cough) drug[2] which was patented in 1956 by Merck & Co.,[3] but has never been used medically as such.
Chemically it is a substituted phenethylamine. It is the N-methylated analog of methylenedioxyphenethylamine (MDPEA). It is a schedule I drug in the USA as a positional isomer of MDA.
Reactions
Reaction of homoarylamine with formaldehyde gives hydrastinine.
See also
- Lobivine (MDDMPEA)
- Hydrastine, an alkaloid derivative of homarylamine
References
<templatestyles src="Reflist/styles.css" />
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ U.S. patent 2820739
Script error: No such module "Check for unknown parameters".
Script error: No such module "Navbox".
Template:Monoamine releasing agents
Script error: No such module "Navbox".